Corcept Therapeutics, Inc. (CORT) Reports Q3 EPS Loss of $0.08
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $91.88 -1.47%
Revenue Growth %: +12.1%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +12.1%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Simulations Plus (SLP) Tops Q3 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
